Delivery Order SPE2DB22D3004-SPE2DB23FQC41
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Citalopram HBR 40 mg tablets. The $16,857.39 Firm Fixed Price Delivery Order has an ultimate completion date of February 15, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,337.32 firm fixed-price delivery order is for the supply of 4,567,476,935 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,302.41 firm fixed-price delivery order contract is for the supply of 4,567,138 units of 20 mg citalopram HBr tablets. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA). The $19,501.66 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for 4,560,750 units of Citalopram HBR 20 mg tablets. The award, valued at $2,629.31, was made by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 28, 2023. The contract is a firm fixed-price delivery order, and no set-aside designation was used. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DB20D2200|SPE2DB23FW98R, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,188.25 firm fixed-price delivery order is for the supply of 4,562,071 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of September 7, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,613.37, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of February 15, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of citalopram HBR 40 mg tablets. The contract has a ceiling value of $6,231.82 and runs through January 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,929.23, is a delivery order for the supply of 4,567,011,559 units of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,342.10, is for the delivery of 4562817233 CITALOPRAM HBR 20 MG TABLET 500S. It is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FQC41Delivery Order
This federal contract award is for the delivery of citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA). The $2,513.74 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 11, 2023 and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/10/23 |